Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles),Length (8mm, 5mm), Setting( Home Care Settings), Application (Glucagon like Peptide -1 Therapy), Mode of Purchase (Over the Counter Purchase, Online Purchase)- Global Forecast to 2031

Market Size
$2.16B
MARKET SIZE, 2026
Projected Market Size
$3.37B
MARKET SIZE, 2031
CAGR
9.3%
CAGR (2026-2031)
Forecast Period
2026-2031
FORECAST PERIOD

PEN NEEDLES MARKET SIZE, SHARE & GROWTH SNAPSHOT

pen-needles-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global pen needles market is projected to grow from USD 2.16 billion in 2026 to USD 3.37 billion by 2031, at a CAGR of 9.3% during the forecast period. The market was valued at USD 1.98 billion in 2025. This is due to rising diabetes prevalence, increasing insulin and injectable biologics use, and patient preference for comfortable, low-pain delivery. Innovations in thinner, shorter needles, safety-engineered designs, and prefilled pen compatibility boost adoption. Growing healthcare access in emerging markets, favorable reimbursement policies, and home care trends further support demand. Manufacturer partnerships, cost reductions, and awareness campaigns will accelerate uptake, while regulatory focus on safety and sustainability shapes future product development and significantly improves patient adherence worldwide.

KEY TAKEAWAYS

  • MARKET SNAPSHOT:
    Base Year Market Size (2025): USD 1.98 Billion
    Current Market Size (2026): USD 2.16 Billion
    Forecast Market Size (2031): USD 3.37 Billion
    CAGR (2026–2031): 9.3%
  • SEGMENT LEADERSHIP:
    Regional Leader: North America accounted for the largest share of 45.1% of the pen needles market in 2025.
    Type Leader: Standard needles accounted for the largest market share of 84% in 2025.
    Length Leader: 8 mm needles accounted for the largest market share in 2025.
    Application Leader: Insulin therapy accounted for the largest share of 79.6% of the pen needles market in 2025.
    Mode of Purchase Leader: Over-the-counter purchases accounted for the largest share of the pen needles market in 2025.
    Setting Leader: Home care accounted for the largest market share in 2025.
  • MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
    Embecta Corp. (US), Novo Nordisk (Denmark), B. Braun (Germany), MTD (Italy), and Terumo Corporation (Japan) were recognized as star players due to their strong product portfolios and geographic presence.
    Montméd Inc. (Canada), Berpu Medical Technology (China), and GlucoRx Limited (UK) have established themselves among startups and SMEs, supported by strong product portfolios and effective business strategies.

The growth of the pen needles market is driven by several key factors, including the rising incidence of chronic diseases, favorable reimbursement policies in certain countries, and decreasing prices of insulin formulations. Opportunities for market players include the growing preference for biosimilar drugs, the potential of emerging economies, and increasing healthcare spending on diabetes management. Supportive government regulations, such as stringent safety standards established by the US FDA and beneficial reimbursement policies, are also expected to promote the adoption of technologically advanced products. Together, these factors are likely to lead to greater utilization of pen needles in healthcare systems.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

A shift in the revenue sources for pen needle manufacturing companies is observed due to the high growth of the market and technological advancements in technology. Technological advancements have prompted end users to update their manufacturing systems. It is believed that these trends will result in significant business opportunities for players operating in the industry. The expected revenue shift will come from standard-gauge pen needles to various products, including pen needles, autoinjectors, pen injections, infusion devices, and pre-filled syringes.

pen-needles-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Rising incidence of chronic diseases
  • Favorable reimbursements in certain countries
RESTRAINTS
Impact
Level
  • Needle anxiety
  • Alternative methods of drug delivery
OPPORTUNITIES
Impact
Level
  • Emerging economies to offer high-growth potential
  • Growing preference for biosimilar drugs
CHALLENGES
Impact
Level
  • Reuse of pen needles
  • Misuse of injection pens

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Rising incidence of chronic diseases

The incidence and prevalence of chronic diseases have increased significantly in recent years. Diseases such as diabetes, osteoporosis, cardiovascular disease (CVD), and multiple sclerosis require daily or weekly drug administration, typically using pen injectors. According to the American Diabetes Association in 2025, over 40 million Americans, or 12% of the population, are living with diabetes. Over 2 million Americans are living with type 1 diabetes, including about 314,000 children and adolescents. The annual cost of this disease has increased to USD 412.9 billion, accounting for one in four health care dollars spent in this country.

Restraint: Needle anxiety

Needle anxiety is a significant barrier to the use of injectable insulin delivery devices, affecting both new users and adult patients. Studies show that 20% to 33% of individuals with diabetes are unwilling to inject themselves due to this fear. Needlestick injuries also pose health risks for healthcare workers, with approximately 600,000 to 800,000 incidents occurring annually in the US, which can lead to serious infections like HIV and Hepatitis. A survey by the American Association of Diabetes Educators found that a similar percentage of diabetics are reluctant to self-inject. Additionally, around 45% of rheumatoid arthritis patients report needle phobia. Since conditions like diabetes and RA require frequent injections, needle anxiety is a major obstacle to market growth. While needle-free drug delivery technology offers some solutions, its application remains limited.

Opportunity: Emerging economies to offer high-growth potential

Emerging markets like China, India, Mexico, and Brazil are rapidly growing, especially in the pen needles market due to the rising prevalence of diabetes. In particular, India and China present significant opportunities for growth, bolstered by increasing healthcare expenditures and infrastructure improvements. According to the International Diabetes Federation (IDF) Diabetes Atlas (2025), India had approximately 89.8 million adults aged 20-79 with diabetes in 2024, a significant rise from 61.3 million in 2011. This figure is projected to reach 156.7 million by 2050. As per the International Monetary Fund (IMF), China's GDP per capita is expected to increase from around USD 10,000 in 2018 to nearly USD 14,000 by 2025. India's GDP per capita also saw a rise from USD 2,348 in 2022/23 to USD 2,530 in 2023/24, enhancing consumer purchasing power. With these promising growth prospects, many global pen needle manufacturers are investing in these regions, taking advantage of low-cost manufacturing to improve profits.

Challenge: Reuse of pen needles

In many regions around the world, the reuse of needle pens is a common practice, with the rates of reuse varying significantly. This can range from as low as 30% to an astonishing 95% of patients who reuse their needles. For example, a study published in the Value in Health Journal reported that 98.35% of patients in China reused their insulin pen needles. The primary reasons for needle reuse include affordability, lack of reimbursement in many developing countries, and convenience. However, the reuse of pen needles poses a significant challenge to market growth, as it reduces the demand for new needles. Additionally, research conducted by the Moscow Regional Research Clinical Institute found that bacteria were present on pen needles after use, and the growth of bacteria increased with repeated reuse. Reusing pen needles can lead to several complications, including poor glycemic control, infections, and lipohypertrophy. These findings raise important safety concerns related to the practice of needle reuse.

PEN NEEDLES MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Develops a wide range of pen needles designed for insulin and GLP-1 delivery, including safety-engineered and ultra-fine variants compatible with multiple pen systems. Ensures precise dosage, minimizes needlestick injuries, and enhances patient comfort and adherence in diabetes management.
company logo
Manufactures high-quality pen needles optimized for its insulin pens and GLP-1 therapies, focusing on smooth penetration and ease of use. Improves injection comfort, ensures consistent insulin delivery, and promotes better self-management among diabetic patients.
company logo
Offers pen needles under the “Omnican” brand, designed for accurate insulin injection with ergonomic grip and minimal penetration force. Provides enhanced safety, precision, and comfort, reducing anxiety associated with daily injections.
company logo
Specializes in pen needles compatible with various injection pens and integrates user-friendly, low-pain technology for chronic disease management. Enhances user experience through ergonomic design, reliable connectivity with injection devices, and improved compliance.
company logo
Produces fine-gauge pen needles featuring advanced Japanese micro-needle technology for accurate and gentle drug delivery. Reduces injection pain, improves dosing precision, and supports patient confidence in self-injection therapy.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The pen needles market ecosystem consists of various elements that play a role in this industry, along with a description of the involved parties. Key participants include manufacturers, distributors, end users, and regulatory bodies. Manufacturers are organizations responsible for the entire process, including research, design, product development, optimization, and product launch. Distributors include third parties and e-commerce platforms that facilitate the marketing of medical devices. End users refer to the patients who utilize pen needles. Additionally, investors and health regulatory bodies serve as significant influencers in this market.

pen-needles-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

pen-needles-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Pen Needles Market, by Type

The standard pen needles segment accounted for the largest share of the global pen needles market because they are relatively cheaper, reliable, and compatible with almost all insulin pens. With the increasing global prevalence of diabetes and other chronic diseases that require injection therapy, demand for cost-effective and efficient delivery solutions of insulin is rising. Standard pen needles are less expensive compared to the advanced ones, which makes them a favorite for many patients and health care providers, especially in regions that are cost-sensitive. The needles are also widely available and can be easily accessed by patients of different kinds. Their simplicity, ease of use, and minimal discomfort make them suitable for better patient compliance, especially for those with long-term diabetes and other diseases, which increases their market dominance.

Pen Needles Market, by Length

The 8 mm length pen needles segment holds the largest share of the global pen needles market due to its wide applicability across diverse patient populations and compatibility with most insulin delivery pens. These needles provide optimal depth for effective subcutaneous insulin delivery, minimizing the risk of intramuscular injection or insulin leakage. Healthcare professionals frequently recommend 8 mm needles for consistent dosing accuracy and patient comfort, particularly for individuals with higher body mass. Their affordability, availability in both standard and safety versions, and ease of use make them suitable for self-administration. Moreover, extensive clinical validation and strong adoption in both developed and emerging markets further reinforce the dominance of the 8 mm segment within the global pen needles market.

Pen Needles Market, by Application

Insulin therapy dominates the global pen needles market as diabetes prevalence continues to surge worldwide, driving higher demand for convenient and precise insulin delivery devices. Pen needles are a key component in daily insulin administration, offering patients a simpler, more comfortable, and accurate injection experience compared to traditional syringes. The growing shift toward insulin pens for self-administration, especially among type 1 and type 2 diabetic patients, further boosts usage. Moreover, government initiatives promoting effective diabetes management, along with technological improvements in needle design—such as finer tips and safety mechanisms—enhance patient compliance and safety. Pharmaceutical collaborations and rising awareness about self-injection practices continue to support the strong market share of insulin therapy in the pen needles segment.

Pen Needles Market, by Mode of Purchase

The online purchase segment is expected to experience the highest CAGR as consumers increasingly shift toward e-commerce. This trend helps to address gaps in supply chain infrastructure and improves access to pen needles, especially for customers in remote or underserved areas where retail outlets and pharmacies are limited. Patients can conveniently order their pen needles from the comfort of their homes using online platforms, which ensures that the products are delivered right to their doorsteps. This minimizes the need for travel, making access to diabetes care more convenient for individuals in isolated locations. Additionally, online businesses offer a wider variety of pen needles at often lower prices, along with attractive discounts that appeal to consumers worldwide.

Pen Needles Market, by Setting

The home care settings segment holds the largest share of the global pen needles market due to the growing preference for self-administration of insulin and other injectable medications. Patients are increasingly managing chronic conditions like diabetes at home to reduce hospital visits and healthcare costs. Pen needles are designed for ease of use, safety, and minimal discomfort, making them ideal for home-based care. The availability of user-friendly insulin pens and online purchasing options has further accelerated adoption. Additionally, growing awareness of diabetes management, supportive reimbursement policies, and the rising elderly population relying on home care contribute significantly to market growth. This trend reflects a broader healthcare shift toward patient empowerment and convenience-driven treatment models worldwide.

REGION

Asia Pacific to be fastest-growing region in global pen needles market during forecast period

The Asia Pacific region is expected to experience the highest CAGR in the global pen needles market. This growth can be largely attributed to the aging population in countries like Japan and China, which contributes to an increase in chronic diseases, particularly diabetes. Older individuals are more susceptible to diabetes, making the use of controlled insulin through devices like pen needles a daily necessity for many patients. The demand for diabetes care products is projected to rise further in aging populations due to improved healthcare infrastructure, greater awareness of diabetes management, and a shift toward more patient-centered solutions. Pen needles are non-invasive and easy to use, making them a popular choice for insulin administration and driving increased adoption across the region.

pen-needles-market Region

PEN NEEDLES MARKET: COMPANY EVALUATION MATRIX

In the pen needles market, Embecta Corp. (Star) has a strong and well-established product portfolio, along with a widespread geographic presence. UltiMed, Inc. (Emerging Leader) has introduced significant product innovations compared to its competitors. While they offer a broad range of products, there are still opportunities for them to expand their geographic reach and accelerate business development.

pen-needles-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

  • Embecta Corp. (US)
  • Novo Nordisk A/S (Denmark)
  • Ypsomed AG (Switzerland)
  • B. Braun SE (Germany)
  • Terumo Corporation (Japan)
  • Owen Mumford (UK)
  • NIPRO Corporation (Japan)
  • Allison Medical, Inc. (US)
  • AdvaCare Pharma (US)
  • Berpu Medical Technology Co., Ltd. (China)
  • ARKRAY, Inc. (Japan)
  • GlucoRx Limited (UK)
  • HTL-STREFA (Poland)
  • UltiMed, Inc. (US)
  • Hindustan Syringes and Medical Devices (India)
  • Artsana Group (Italy)
  • PromiseMed Medical Devices Inc. (Canada)
  • Montmed, Inc. (Canada)
  • Trividia Health, Inc. (US)
  • VOGT Medical Vertrieb GmbH (Germany)
  • Van Heek Medical (Netherlands)
  • Simple Diagnostics (US)
  • IYON Medical (Turkey)
  • Links Medical Products, Inc. (US)
  • MHC Medical Products, LLC (US)

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 1.98 Billion
Market Forecast in 2026 (Value) USD 2.16 Billion
Market Forecast in 2031 (Value) USD 3.37 Billion
Growth Rate CAGR OF 9.3% FROM 2026-2031
Years Considered 2024–2031
Base Year 2025
Forecast Period 2026–2031
Units Considered Value (USD Million/Billion), Volume (Thousand Units)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered
  • By Type:
    • Standard Pen Needles
    • Safety Pen Needles
  • By Length:
    • 8 mm
    • 5 mm
    • 6 mm
    • 4 mm
    • 12 mm
    • 10 mm
  • By Application:
    • Insulin Therapy
    • GLP-1 Therapy
    • Growth Hormone Therapy
    • Osteoporosis
    • Other Applications
  • By Mode of Purchase:
    • Prescription-based
    • Over the Counter (OTC)
    • Online Purchase
    • Other Mode of Purchase
  • By End User:
    • Home Care
    • Hospitals and Clinics
    • Other End User
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa, GCC Countries

WHAT IS IN IT FOR YOU: PEN NEEDLES MARKET REPORT CONTENT GUIDE

pen-needles-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Product Analysis Comparison of pen needle types by length (4 mm, 5 mm, 6 mm, 8 mm, and 12 mm), needle gauge, and compatibility with various insulin and GLP-1 pens. Assessment of technological innovations such as ultra-thin wall designs, safety-engineered needles, and low-friction coatings to enhance injection comfort and precision.
Company Information Profiles of key manufacturers such as BD (US), Novo Nordisk (Denmark), MTD (Italy), B. Braun (Germany), Terumo (Japan), and Owen Mumford (UK). Market share benchmarking and competitive landscape of leading players across North America, Europe, Asia Pacific, and the Middle East.
Geographic Analysis Detailed regional assessment of North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Country-level sizing, CAGR forecasts, and adoption analysis for major markets such as the US, Germany, Japan, China, and India.

RECENT DEVELOPMENTS

  • May 2026 : In May 2026, Embecta completed the acquisition of Owen Mumford, a UK-based manufacturer of drug-delivery devices and pen needles, expanding its portfolio beyond traditional insulin delivery products and strengthening its position in the global injection devices market.
  • March 2024 : Medical Technology and Devices (MTD) (Italy) acquired Ypsomed’s pen needle and blood glucose monitoring (BGM) businesses. This strategic move will solidify MTD’s position as a globally leading player in pen needle production and will enhance its comprehensive solution portfolio for diabetes care.
  • March 2023 : Novo Nordisk A/S, based in Denmark, plans to expand its presence in the US by establishing one of the largest R&D hubs outside of Denmark, located near the greater Boston metro area.
  • January 2023 : Embecta Corp. (US) expanded its presence in New Jersey with the opening of a new global headquarters in Parsippany, New Jersey.
  • November 2022 : Embecta Corp. and Intuity Medical, Inc. have entered into a co-promotional agreement. Under this agreement, Embecta’s sales representatives will promote Intuity Medical's innovative POGO Automatic Blood Glucose Monitoring System to healthcare professionals in the US.

 

Table of Contents

checkmarkExclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
15
2
EXECUTIVE SUMMARY
 
 
 
 
3
PREMIUM INSIGHTS
 
 
 
 
4
MARKET OVERVIEW
Summarizes the competitive environment, macro signals, and segment-level movements driving market outcomes.
 
 
 
 
 
4.1
INTRODUCTION
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
4.2.4
CHALLENGES
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
5
INDUSTRY TRENDS
Presents a concise view of industry direction, strategic priorities, and key indicators influencing market momentum.
 
 
 
 
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
5.2
MACROECONOMIC OUTLOOK
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
5.2.2
GDP TRENDS AND FORECAST
 
 
 
 
5.2.3
TRENDS IN GLOBAL DRUG DELIVERY INDUSTRY
 
 
 
5.3
SUPPLY CHAIN ANALYSIS
 
 
 
 
 
5.4
VALUE CHAIN ANALYSIS
 
 
 
 
 
5.5
ECOSYSTEM ANALYSIS
 
 
 
 
 
5.6
PRICING ANALYSIS
 
 
 
 
 
 
5.6.1
AVERAGE SELLING PRICE TREND, BY PRODUCT, 2023–2025
 
 
 
 
5.6.2
AVERAGE SELLING PRICE TREND, BY REGION, 2023–2025
 
 
 
5.7
TRADE ANALYSIS
 
 
 
 
 
5.8
KEY CONFERENCES AND EVENTS, 2026–2027
 
 
 
 
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
5.10
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
5.11
CASE STUDY ANALYSIS
 
 
 
 
5.12
IMPACT OF 2025 US TARIFF – PEN NEEDLES MARKET
 
 
 
 
 
 
5.12.1
INTRODUCTION
 
 
 
 
5.12.2
KEY TARIFF RATES
 
 
 
 
5.12.3
PRICE IMPACT ANALYSIS
 
 
 
 
5.12.4
IMPACT ON COUNTRIES/REGIONS
 
 
 
 
 
5.12.4.1
US
 
 
 
 
5.12.4.2
EUROPE
 
 
 
 
5.12.4.3
ASIA PACIFIC
 
 
 
5.12.5
IMPACT ON END-USE INDUSTRIES
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
 
 
 
 
 
6.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
6.3
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
6.4
PATENT ANALYSIS
 
 
 
 
 
6.5
FUTURE APPLICATIONS
 
 
 
 
6.6
IMPACT OF AI/GEN AI ON PEN NEEDLES MARKET
 
 
 
 
 
 
6.6.1
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
6.6.2
BEST PRACTICES IN PEN NEEDLES PROCESSING
 
 
 
 
6.6.3
CASE STUDIES OF AI IMPLEMENTATION IN PEN NEEDLES MARKET
 
 
 
 
6.6.4
INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
6.6.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PEN NEEDLES MARKET
 
 
7
REGULATORY LANDSCAPE
 
 
 
 
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
 
 
 
 
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
 
 
 
 
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
9
PEN NEEDLES MARKET, BY TYPE (USD MILLION AND VOLUME IN THOUSAND UNITS, 2024–2031)
 
 
 
 
 
9.1
INTRODUCTION
 
 
 
 
9.2
STANDARD PEN NEEDLES
 
 
 
 
9.3
SAFETY PEN NEEDLES
 
 
 
10
PEN NEEDLES MARKET, BY LENGTH (USD MILLION, 2024–2031)
 
 
 
 
 
10.1
INTRODUCTION
 
 
 
 
10.2
8 MM
 
 
 
 
10.3
5 MM
 
 
 
 
10.4
6 MM
 
 
 
 
10.5
4 MM
 
 
 
 
10.6
12 MM
 
 
 
 
10.7
10 MM
 
 
 
11
PEN NEEDLES MARKET, BY SETTING (USD MILLION, 2024–2031)
 
 
 
 
 
11.1
INTRODUCTION
 
 
 
 
11.2
HOME CARE SETTINGS
 
 
 
 
11.3
HOSPITALS AND CLINICS
 
 
 
 
11.4
OTHER SETTINGS
 
 
 
12
PEN NEEDLES MARKET, BY APPLICATION (USD MILLION, 2024–2031)
 
 
 
 
 
12.1
INTRODUCTION
 
 
 
 
12.2
INSULIN THERAPY
 
 
 
 
12.3
GLUCAGON-LIKE PEPTIDE-1 THERAPY
 
 
 
 
12.4
GROWTH HORMONE THERAPY
 
 
 
 
12.5
OSTEOPOROSIS
 
 
 
 
12.6
OTHER APPLICATIONS
 
 
 
13
PEN NEEDLES MARKET, BY MODE OF PURCHASE (USD MILLION, 2024–2031)
 
 
 
 
 
13.1
INTRODUCTION
 
 
 
 
13.2
PRESCRIPTION-BASED PURCHASE
 
 
 
 
13.3
OVER-THE-COUNTER PURCHASE
 
 
 
 
13.4
ONLINE PURCHASE
 
 
 
 
13.5
OTHER MODES OF PURCHASE
 
 
 
14
PEN NEEDLES MARKET, BY REGION (USD MILLION, 2024–2031)
 
 
 
 
 
14.1
INTRODUCTION
 
 
 
 
14.2
NORTH AMERICA
 
 
 
 
 
14.2.1
US
 
 
 
 
14.2.2
CANADA
 
 
 
14.3
EUROPE
 
 
 
 
 
14.3.1
GERMANY
 
 
 
 
14.3.2
FRANCE
 
 
 
 
14.3.3
UK
 
 
 
 
14.3.4
ITALY
 
 
 
 
14.3.5
SPAIN
 
 
 
 
14.3.6
REST OF EUROPE
 
 
 
14.4
ASIA PACIFIC
 
 
 
 
 
14.4.1
CHINA
 
 
 
 
14.4.2
JAPAN
 
 
 
 
14.4.3
INDIA
 
 
 
 
14.4.4
AUSTRALIA & NEW ZEALAND
 
 
 
 
14.4.5
SOUTH KOREA
 
 
 
 
14.4.6
SOUTHEAST ASIA
 
 
 
 
14.4.7
REST OF ASIA PACIFIC
 
 
 
14.5
LATIN AMERICA
 
 
 
 
 
14.5.1
BRAZIL
 
 
 
 
14.5.2
MEXICO
 
 
 
 
14.5.3
ARGENTINA
 
 
 
 
14.5.4
REST OF LATIN AMERICA
 
 
 
14.6
MIDDLE EAST & AFRICA
 
 
 
 
14.7
GCC COUNTRIES
 
 
 
15
COMPETITIVE LANDSCAPE
 
 
 
 
 
15.1
OVERVIEW
 
 
 
 
15.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN
 
 
 
 
15.3
REVENUE ANALYSIS
 
 
 
 
 
15.4
MARKET SHARE ANALYSIS
 
 
 
 
 
 
15.4.1
GLOBAL PEN NEEDLES MARKET SHARE ANALYSIS,
 
 
 
 
15.4.2
US PEN NEEDLES MARKET SHARE ANALYSIS,
 
 
 
15.5
BRAND COMPARISON
 
 
 
 
 
15.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
 
 
 
 
 
 
15.6.1
STARS
 
 
 
 
15.6.2
EMERGING LEADERS
 
 
 
 
15.6.3
PERVASIVE PLAYERS
 
 
 
 
15.6.4
PARTICIPANTS
 
 
 
 
15.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
 
 
 
 
 
15.6.5.1
COMPANY FOOTPRINT
 
 
 
 
15.6.5.2
REGION FOOTPRINT
 
 
 
 
15.6.5.3
TYPE FOOTPRINT
 
 
 
 
15.6.5.4
LENGTH FOOTPRINT
 
 
 
 
15.6.5.5
MODE OF PURCHASE FOOTPRINT
 
 
 
 
15.6.5.6
SETTING FOOTPRINT
 
 
 
 
15.6.5.7
APPLICATION FOOTPRINT
 
 
15.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
 
 
 
 
 
 
15.7.1
PROGRESSIVE COMPANIES
 
 
 
 
15.7.2
RESPONSIVE COMPANIES
 
 
 
 
15.7.3
DYNAMIC COMPANIES
 
 
 
 
15.7.4
STARTING BLOCKS
 
 
 
 
15.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
 
 
 
 
 
15.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
15.7.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
15.8
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
15.9
COMPETITIVE SCENARIO
 
 
 
 
 
15.9.1
PRODUCT LAUNCHES
 
 
 
 
15.9.2
DEALS
 
 
 
 
15.9.3
EXPANSIONS
 
 
16
COMPANY PROFILES
 
 
 
 
 
16.1
KEY PLAYERS
 
 
 
 
 
16.1.1
BECTON, DICKINSON AND COMPANY
 
 
 
 
16.1.2
NOVO NORDISK A/S
 
 
 
 
16.1.3
MEDICAL TECHNOLOGY AND DEVICES (MTD) GROUP
 
 
 
 
16.1.4
B. BRAUN MELSUNGEN AG
 
 
 
 
16.1.5
TERUMO CORPORATION
 
 
 
 
16.1.6
NIPRO CORPORATION
 
 
 
 
16.1.7
OWEN MUMFORD
 
 
 
 
16.1.8
ARKRAY
 
 
 
 
16.1.9
ULTIMED
 
 
 
 
16.1.10
HINDUSTAN SYRINGES AND MEDICAL DEVICES
 
 
 
16.2
OTHER PLAYERS
 
 
 
 
 
16.2.1
MONTMED
 
 
 
 
16.2.2
HTL-STREFA
 
 
 
 
16.2.3
ALLISON MEDICAL, INC.
 
 
 
 
16.2.4
GLUCORX
 
 
 
 
16.2.5
BERPU MEDICAL TECHNOLOGY
 
 
 
 
16.2.6
ADVACARE PHARMA
 
 
 
 
16.2.7
ARTSANA GROUP
 
 
 
 
16.2.8
PROMISEMED DIABETES CARE
 
 
 
 
16.2.9
TRIVIDIA HEALTH
 
 
 
 
16.2.10
VOGT MEDICAL VERTRIEB
 
 
 
 
16.2.11
VAN HEEK MEDICAL
 
 
 
 
16.2.12
SIMPLE DIAGNOSTICS
 
 
 
 
16.2.13
IYON
 
 
 
 
16.2.14
LINKS MEDICAL PRODUCTS
 
 
 
 
16.2.15
MHC MEDICAL PRODUCTS
 
 
17
RESEARCH METHODOLOGY
 
 
 
 
 
17.1
RESEARCH DATA
 
 
 
 
 
17.1.1
SECONDARY DATA
 
 
 
 
 
17.1.1.1
KEY DATA FROM SECONDARY SOURCES
 
 
 
17.1.2
PRIMARY DATA
 
 
 
 
 
17.1.2.1
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
17.1.2.2
KEY PRIMARY PARTICIPANTS
 
 
 
 
17.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
17.1.2.4
KEY INDUSTRY INSIGHTS
 
 
17.2
MARKET SIZE ESTIMATION
 
 
 
 
 
17.2.1
BOTTOM-UP APPROACH
 
 
 
 
17.2.2
TOP-DOWN APPROACH
 
 
 
17.3
MARKET FORECAST APPROACH
 
 
 
 
 
17.3.1
SUPPLY SIDE
 
 
 
 
17.3.2
DEMAND SIDE
 
 
 
17.4
DATA TRIANGULATION
 
 
 
 
17.5
FACTOR ANALYSIS
 
 
 
 
17.6
RESEARCH ASSUMPTIONS
 
 
 
 
17.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
 
 
 
18
APPENDIX
 
 
 
 
 
18.1
DISCUSSION GUIDE
 
 
 
 
18.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
18.3
CUSTOMIZATION OPTIONS
 
 
 
 
18.4
RELATED REPORTS
 
 
 
 
18.5
AUTHOR DETAILS
 
 
 

Methodology

This research study involved the extensive use of both primary and secondary sources. It involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.

Secondary Research

This research study involved the wide use of secondary sources such as directories, databases such as D&B Hoovers, Bloomberg Businessweek, and Factiva; white papers; and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the pen needles market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various supply-side and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the pen needles market. Primary sources from the demand side included personnel from hospitals and clinics, researchers, lab technicians, purchase managers, and stakeholders from corporate & government bodies.

A breakdown of the primary respondents for the pen needles market (supply side) market is provided below:

Pen Needles Market
 Size, and Share

Note 1: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
Note 2: C-level executives include CEOs, COOs, CTOs, and VPs.
Note 3: Other primaries include sales managers, marketing managers, and product managers.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size for pen needles was determined using data from four different sources, which will be discussed below. Each method was evaluated, and a weighted average was calculated based on the number of assumptions made by each approach. The market size for pen needles was ultimately derived from these three distinct sources, as detailed in the following sections.

Pen Needles Market: Bottom-up Approach & Top-down Approach

Pen Needles Market Top Down and Bottom Up Approach

Data Triangulation

The entire market was divided into five segments to determine its size. Data triangulation and market breakdown processes were applied where necessary to complete the market engineering process and accurately arrive at the statistics for each segment.

To estimate the market size and forecast growth, secondary data from both paid and unpaid sources were utilized. A thorough analysis of the sales of pen needles from major players helped establish their market rankings. Due to data limitations, the revenue share for certain companies was calculated based on an in-depth examination of their product portfolios and individual sales performance. This information was verified at each stage through detailed interviews with industry professionals.

Market Definition

A pen needle is a hollow needle fixed within a plastic hub and connected to injectable pens. These pen needles come in various lengths and diameters, making them suitable for use by both healthcare professionals and patients to administer injectable medications. They are electro-polished to ensure smooth, thin, and fine-point tips, which enhance comfort and ease during penetration. Pen needles offer a modern alternative for drug delivery compared to traditional injection methods.

Key Stakeholders

  • Manufacturers of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies
  • Original equipment manufacturing companies
  • Suppliers and distributors of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies
  • Healthcare service providers
  • Teaching hospitals and academic medical centers
  • Health insurance players
  • Government bodies/municipal corporations
  • Regulatory bodies
  • Business research and consulting service providers
  • Authorities framing reimbursement policies for pen needles
  • Venture capitalists
  • Market research and consulting firms

Report Objectives

  • To define, describe, and forecast the pen needles market based on type, length, application, mode of purchase, setting, and region.
  • To provide detailed information about the major factors influencing the market growth (such as drivers, restraints, challenges, and opportunities)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall pen needles market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the pen needles market in North America, Europe, the Asia Pacific, Latin America, Middle East & Africa, and GCC Countries
  • To profile the key players and comprehensively analyze their market shares and core competencies in the pen needles market
  • To track and analyze competitive developments such as partnerships, expansions, acquisitions, collaborations, product launches, agreements, and other developments in the pen needles market
  • To benchmark players within the pen needles market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings.

Available customizations:

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

  • Further breakdown of the Rest of Europe pen needles market into Denmark and Norway, among others
  • Further breakdown of the Rest of Asia Pacific pen needles market into countries such as Vietnam

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Pen Needles Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Pen Needles Market

avtar

User

Nov, 2019

how about Owen Mumford pen needle market? any chance their able grow more than others?.

DMCA.com Protection Status
popup img